CCL1 is believed to have the dual purpose of predisposing subjects to both obesity and insulin resistance; this assumption seems plausible in light of the significantly higher levels of CCL1 in T2DM subjects in all four groups, A to D, ranging from normal body weight to severe obesity. The gene discussed is CCL1; the disease is Obesity.